NCT06342323View on ClinicalTrials.gov

The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy

RecruitingOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

October 8, 2023

Primary Completion Date

October 7, 2024

Study Completion Date

October 7, 2025

Conditions
Lung CancerLiver CancerPancreatic CancerRenal Cell Carcinoma
Interventions
RADIATION

SBRT

the fiducial marker was implanted with 3D template assistance under CT guidance

Trial Locations (1)

100191

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER